Vnitr Lek 2016, 62(7-8):671-677

Prevention and therapy of sarcopenia in the ageing

Zdeněk Zadák
Centrum pro výzkum a vývoj III. interní gerontometabolické kliniky LF UK FN Hradec Králové

Sarcopenia is one of the severe disorders associated with nutritional imbalance. While sarcopenia is an inseparable part of the process of ageing as people get older, it plays a vital role in pathological situations such as protein-calorie and kwashiorkor malnutrition, it accompanies various diseases of rheumatic character and is an almost ever-present feature of the clinical picture of oncological patients. Sarcopenia in people under strain is fatally manifested mainly in the elderly, medically fragile patients. In view of the fact that sarcopenia is the decisive factor regarding the course of chronic as well as acute illnesses, it must be diagnosed, monitored and appropriately treated in time. Although nutrition is not the only factor involved especially in older age in the development of sarcopenia, the type of nutritional support and, in the new era, particularly nutritional pharmacology, form the underlying principles of the approach to the comprehensive care of the patient.

Keywords: ageing; lipids; malnutrition; proteosynthesis; sarcopenia

Received: July 21, 2016; Accepted: August 2, 2016; Published: July 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zadák Z. Prevention and therapy of sarcopenia in the ageing. Vnitr Lek. 2016;62(7-8):671-677.
Download citation

References

  1. Zadák Z. Výživa v intenzivní péči. 2.ed. Grada: Praha 2008. ISBN 978-80-247-2844-5.
  2. Zadák Z, Havel E et al. Intenzivní medicína na principech vnitřního lékařství. Grada: Praha 2007. ISBN 978-80-247-2099-9.
  3. Bahat G, Ilhan B. Sarcopenia and the cardiometabolic syndrome: A narrative review. Eur Geriatr Med 2016; 7(3): 220-223. Go to original source...
  4. Thomas DR. Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007; 26(4): 389-399. Go to original source... Go to PubMed...
  5. Batsis JA, Mackenzie TA, Jones JD et al. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey. Clin Nutr 2016; pii: S0261-5614(16)30020-6. Dostupné z DOI: <http://dx.doi.org/10.1016/j.clnu.2016.03.028>. Go to original source... Go to PubMed...
  6. Acharyya S, Butchbach MER, Sahenk Z et al. Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 2005; 8(5): 421-432. Go to original source... Go to PubMed...
  7. Arik G, Ulger Z. Vitamin D in sarcopenia: Understanding its role in pathogenesis, prevention and treatment. Eur Geriatr Med 2016; 7(3): 207-213. Go to original source...
  8. Zadák Z, Květina J. Metodologie předklinického a klinického výzkumu v metabolismu, výživě, imunologii a farmakologii. Galén: Praha 2011. ISBN 978-80-7262-748-6.
  9. Kalinkovich A, Livshits G. Sarcopenia - The search for emerging biomarkers. Ageing Res Rev 2015; 22: 58-71. Go to original source... Go to PubMed...
  10. Chen JL, Walton KL, Winbanks CE et al. Elevated expression of activins promotes muscle wasting and cachexia. FASEB J 2014; 28(4): 1711-1723. Go to original source... Go to PubMed...
  11. Boström PA, Fernández-Real JM, Mantzoros C. Irisin in humans: recent advances and questions for future research. Metabolism 2014; 63(2): 178-180. Go to original source... Go to PubMed...
  12. Sergi G, Trevisan C, Veronese N et al. Imaging of sarcopenia. Eur J Radiol 2016; 85(8): 1519-1524. Go to original source... Go to PubMed...
  13. Lardiés-Sánchez B, Sanz-Paris A, Boj-Carceller D et al. Systematic review: Prevalence of sarcopenia in ageing people using bioelectrical impedance analysis to assess muscle mass. Eur Geriatr Med 2016; 7(3): 256-261. Go to original source...
  14. Kim JS, Wilson JM, Lee SR. Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants. J Nutr Biochem 2010; 21(1): 1-13. Go to original source... Go to PubMed...
  15. Song YH, Song JL, Delafontaine P et al. The therapeutic potential of IGF-I in skeletal muscle repair. Trends Endocrinol Metab 2013; 24(6): 310-319. Go to original source... Go to PubMed...
  16. Nissen SL, Abumrad NN. Nutritional role of the leucine metabolite β-hydroxy β-methylbutyrate (HMB). J Nutr Biochem 1997; 8(6): 300-311. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.